Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Potter

Showing results (921-930 of 1,045) with videos related to

Pageof 105
Sort By:
Molecular Pharmacology|January 7, 2010
Human carboxylesterase 1 stereoselectively binds the nerve agent cyclosarin and spontaneously hydrolyzes the nerve agent sarinAndrew C Hemmert, Tamara C Otto, Monika Wierdl, et al.
Cancer Research|July 10, 2007
Preferential expression of very late antigen-4 on type 1 CTL cells plays a critical role in trafficking into central nervous system tumorsKotaro Sasaki, Xinmei Zhu, Cecilia Vasquez, et al.
Ethnicity & Disease|August 18, 2018
Developing a Medical School Curriculum on Racism: Multidisciplinary, Multiracial Conversations Informed by Public Health Critical Race Praxis (PHCRP)Rachel R Hardeman, Diana Burgess, Katy Murphy, et al.
Health and Quality of Life Outcomes|August 16, 2020
Estimating EQ-5D utilities based on the Short-Form Long Term Conditions Questionnaire (LTCQ-8)Apostolos Tsiachristas, Caroline M Potter, Stephen Rocks, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|February 14, 2026
Delivering Inclusive Cultural Offers for Social Prescribing: A Realist Evaluation Involving Older People From Global Majority Backgrounds and Cultural Sector Providers in the UKDebra Westlake, Kamal R Mahtani, Geoffrey Wong, et al.
British Journal of Haematology|February 13, 2001
Analysis of ETV6/AML1 abnormalities in acute lymphoblastic leukaemia: incidence, alternative spliced forms and minimal residual disease valueR Codrington, H E O'Connor, G R Jalali, et al.
Cancer Gene Therapy|January 12, 2008
An improved human carboxylesterase for enzyme/prodrug therapy with CPT-11M Wierdl, L Tsurkan, J L Hyatt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2014
Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstem and nonbrainstem gliomasIan F Pollack, Regina I Jakacki, Lisa H Butterfield, et al.
Journal of Applied Toxicology : JAT|June 25, 2019
Lens cholesterol biosynthesis inhibition: A common mechanism of cataract formation in laboratory animals by pharmaceutical productsMichael D Aleo, Colleen M Doshna, Daniel Baltrukonis, et al.
Clinical Colorectal Cancer|August 24, 2011
A phase I/II study of capecitabine given on a week on/week off schedule combined with bevacizumab and oxaliplatin for patients with untreated advanced colorectal cancerRajesh Sehgal, Barry C Lembersky, Kiran K Rajasenan, et al.
Pageof 105

Showing results (921-930 of 1,045) with videos related to

Sort By:
Pageof 105
Molecular Pharmacology|January 7, 2010
Human carboxylesterase 1 stereoselectively binds the nerve agent cyclosarin and spontaneously hydrolyzes the nerve agent sarinAndrew C Hemmert, Tamara C Otto, Monika Wierdl, et al.
Cancer Research|July 10, 2007
Preferential expression of very late antigen-4 on type 1 CTL cells plays a critical role in trafficking into central nervous system tumorsKotaro Sasaki, Xinmei Zhu, Cecilia Vasquez, et al.
Ethnicity & Disease|August 18, 2018
Developing a Medical School Curriculum on Racism: Multidisciplinary, Multiracial Conversations Informed by Public Health Critical Race Praxis (PHCRP)Rachel R Hardeman, Diana Burgess, Katy Murphy, et al.
Health and Quality of Life Outcomes|August 16, 2020
Estimating EQ-5D utilities based on the Short-Form Long Term Conditions Questionnaire (LTCQ-8)Apostolos Tsiachristas, Caroline M Potter, Stephen Rocks, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|February 14, 2026
Delivering Inclusive Cultural Offers for Social Prescribing: A Realist Evaluation Involving Older People From Global Majority Backgrounds and Cultural Sector Providers in the UKDebra Westlake, Kamal R Mahtani, Geoffrey Wong, et al.
British Journal of Haematology|February 13, 2001
Analysis of ETV6/AML1 abnormalities in acute lymphoblastic leukaemia: incidence, alternative spliced forms and minimal residual disease valueR Codrington, H E O'Connor, G R Jalali, et al.
Cancer Gene Therapy|January 12, 2008
An improved human carboxylesterase for enzyme/prodrug therapy with CPT-11M Wierdl, L Tsurkan, J L Hyatt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2014
Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstem and nonbrainstem gliomasIan F Pollack, Regina I Jakacki, Lisa H Butterfield, et al.
Journal of Applied Toxicology : JAT|June 25, 2019
Lens cholesterol biosynthesis inhibition: A common mechanism of cataract formation in laboratory animals by pharmaceutical productsMichael D Aleo, Colleen M Doshna, Daniel Baltrukonis, et al.
Clinical Colorectal Cancer|August 24, 2011
A phase I/II study of capecitabine given on a week on/week off schedule combined with bevacizumab and oxaliplatin for patients with untreated advanced colorectal cancerRajesh Sehgal, Barry C Lembersky, Kiran K Rajasenan, et al.
Pageof 105